Simple Summary Gastric cancer is still one of the leading causes of death caused by cancer
in developing countries. The emerging role of immunotherapy in cancer treatment has led to …

Multidisciplinary team from three universities based in the “Centro” Region of Portugal
developed diverse approaches as parts of a project dedicated to enhancing and expanding …

Pharmacogenomics (PGx) is considered an emergent field in developing countries.
Research on PGx in the Latin American and the Caribbean (LAC) region remains scarce …

Introduction: The cytochrome P450 enzyme subfamilies, including CYP3A4 and CYP1A2,
have a major role in metabolism of a range of drugs including several anti-cancer …

Pharmacogenetic studies the influence of inherited characteristics on medication. While
different from pharmacogenomics, which is a study of the entire genome in relation to …

Background/Objectives: Pharmacogenetics (PGx) aims to identify individuals more likely to
suffer from adverse reactions or therapeutic failure in drug treatments. However, despite …

Studies found a strong association between HLA-B* 13: 01 allele and co-trimoxazole-
induced severe cutaneous adverse reactions (SCARs). Genetic screening before initiation of …

With the aim of integrating clinical pharmacology with pharmacogenomics and providing a
platform to gather clinicians, academicians, diagnostic laboratory personnel and scientists …

Introduction Genetic variations impact drug response, driving the need for personalised
medicine through pre-emptive pharmacogenetic testing. However, the adoption of pre …

Precision medicine envisages the integration of an individual's clinical and biological
features obtained from laboratory tests, imaging, high-throughput omics and health records …